EGF Theramed Health Corp. (CSE:TMED)

EGF Theramed Health Income Statement

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cost of Revenue	-	-	0	-	-	0.11
Gross Profit	-	-	-0	-	-	-0.11
Selling, General & Admin	0.26	0.26	0.23	0.35	0.97	0.69
Operating Expenses	0.26	0.26	0.23	0.35	0.97	0.76
Operating Income	-0.26	-0.26	-0.23	-0.35	-0.97	-0.87
Interest Expense	-0.07	-0.07	-0.06	-0.04	-0.01	-0.37
Interest & Investment Income	-	-	0.02	-	0	0
Currency Exchange Gain (Loss)	-0.01	0	-0.04	-0.01	-0.01	0.07
Other Non Operating Income (Expenses)	-2.13	-2.13	0.01	-0.24	-0.02	-0.04
EBT Excluding Unusual Items	-2.48	-2.46	-0.3	-0.64	-1.02	-1.2
Asset Writedown	-	-	-	-	-0.35	-
Other Unusual Items	0.06	0.06	-	-	-	0.46
Pretax Income	-2.42	-2.4	-0.3	-0.64	-1.36	-0.74
Income Tax Expense	0.83	0.83	-	-	-	-
Earnings From Continuing Operations	-3.25	-3.23	-0.3	-0.64	-1.36	-0.74
Minority Interest in Earnings	0.03	0.02	0.03	0.02	0.01	-0.23
Net Income	-3.22	-3.21	-0.27	-0.62	-1.35	-0.97
Net Income to Common	-3.22	-3.21	-0.27	-0.62	-1.35	-0.97
Shares Outstanding (Basic)	12	12	11	10	2	1
Shares Outstanding (Diluted)	12	12	11	10	2	1
Shares Change (YoY)	1.66%	3.43%	12.24%	363.47%	100.98%	298.94%
EPS (Basic)	-0.28	-0.28	-0.02	-0.06	-0.63	-0.91
EPS (Diluted)	-0.28	-0.28	-0.02	-0.06	-0.63	-0.91
EBIT	-0.26	-0.26	-0.23	-0.35	-0.97	-0.87

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.